Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.
Abstract
Two recent studies (ABC-02 [UK] and BT22 [Japan]) have demonstrated the superiority of cisplatin and gemcitabine (CisGem) chemotherapy over gemcitabine (Gem) alone for patients with pathologically proven advanced biliary tract cancer (BTC: cholangiocarcinoma, gallbladder and ampullary cancers). This pre-planned analysis evaluates the efficacy of CisGem with increased statistical power.Citation
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. 2013: Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdt540PubMed ID
24351397Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdt540
Scopus Count
Collections
Related articles
- Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
- Authors: Croitoru A, Gramaticu I, Dinu I, Gheorghe L, Alexandrescu S, Buica F, Luca I, Becheanu G, Herlea V, Simionov I, Hrehoret D, Lupescu I, Popescu I, Diculescu M
- Issue date: 2012 Sep
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease.
- Authors: Lamarca A, Benafif S, Ross P, Bridgewater J, Valle JW
- Issue date: 2015 Sep
- Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China.
- Authors: Shi C, Li Y, Yang C, Qiao L, Tang L, Zheng Y, Chen X, Qian Y, Yang J, Wu D, Xie F
- Issue date: 2022
- Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
- Authors: Song BG, Park JK, Kim HS, Kim K, Park JK, Lee KH, Lee KT, Lee JK
- Issue date: 2019 Jun
- Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
- Authors: Abdel-Rahman O, Elsayed Z, Elhalawani H
- Issue date: 2018 Apr 6